HALIFAX, Nova Scotia, August 13, 2021–(Enterprise WIRE)–Appili Therapeutics Inc. (TSX:APLI OTCQX: APLIF) (the “Firm” or “Appili”), a biopharmaceutical firm establishing anti-infective drug candidates, currently announced
HALIFAX, Nova Scotia, August 13, 2021–(Enterprise WIRE)–Appili Therapeutics Inc. (TSX:APLI OTCQX: APLIF) (the “Firm” or “Appili”), a biopharmaceutical firm establishing anti-infective drug candidates, currently announced